NM_016306.6:c.100C>T
Variant summary
Our verdict is Likely pathogenic. Variant got 8 ACMG points: 12P and 4B. PVS1PM2PP5_ModerateBS2
The NM_016306.6(DNAJB11):c.100C>T(p.Arg34*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000345 in 1,449,154 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_016306.6 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 8 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000415 AC: 1AN: 240806Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 130172
GnomAD4 exome AF: 0.00000345 AC: 5AN: 1449154Hom.: 0 Cov.: 30 AF XY: 0.00000139 AC XY: 1AN XY: 720822
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not provided Pathogenic:1
For these reasons, this variant has been classified as Pathogenic. This premature translational stop signal has been observed in individual(s) with polycystic kidney disease (PMID: 32631624). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This sequence change creates a premature translational stop signal (p.Arg34*) in the DNAJB11 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in DNAJB11 are known to be pathogenic (PMID: 32631624). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at